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Giant basal cell carcinoma presenting
as a chronic leg ulcer
A 78-year-old man presented to our department with a 5-
year history of a non-healing ulcer on his right leg, previ-
ously diagnosed as a venous leg ulcer. It started as a small
ulcer located on right perimalleolar region and despite
several wound care measures, it progressively increased.
Medical history was remarkable for benign prostatic
hypertrophy and chronic venous insufficiency. No risk
factors for atherosclerotic occlusion were present. Physi-
cal examination revealed a large circumferential and irreg-
ular shaped ulcer, measuring 14 cm at its largest diameter
and occupying the median third of right leg (figure 1A).
Its borders were sharply demarcated and raised. The
wound bed was hemorrhagic with no visible granulation
tissue. Clinical signs of arterial insufficiency were not
detected.
Lower limb duplex ultrasonography confirmed bilateral
venous insufficiency and arterial stenoses were excluded.
A complete laboratory work-up was performed, excluding
hematologic, infectious and autoimmune conditions.
A biopsy taken from the ulcer margin showed gland-like
structures surrounded by strands of basaloid cells in the
dermis and subcutaneous tissue (figure 1B). Those find-
ings were compatible with adenoid basal cell carcinoma
(BCC). Several biopsies were taken from the ulcer borders
and wound bed and all of them supported the diagnosis of
primary BCC (figure 1A). Imaging studies excluded osse-
ous involvement and regional and/or distant metastasis.
The patient refused surgical treatment and radiotherapy
was started at a total delivery dose of 60 gray (Gy),
divided in 2 Gy fractions, over 6 weeks. This course
resulted in a decrease in the depth and extension of the
wound. Healing was complicated by local bacterial infec-
tions, which were managed with systemic antibiotics,
wound debridement and silver dressings. During a 10-
month follow-up period, a sustained improvement of the
leg ulcer was observed (figure 1C). At present, no clinical
and/or histological recurrences have been detected.
Chronic ulceration of the lower leg is a frequent condition,
with a prevalence of 1-5% over 65 years of age. The most
common causes are venous insufficiency, peripheral arterial
disease and diabetes [1]. Malignancies may also present as a
leg ulcers, most frequently squamous cell carcinoma (SCC)
and BCC, which can be primary or secondary to malignant
transformation of chronic ulceration. Chronic wounds may
degenerate into SCC and less frequently into BCC. Malig-
nant changes usually manifest as an abnormal vegetating
lesion [2]. In our patient, the diagnosis of primary BCC
was strongly supported by the positive histopathogical
ulcer mapping and by the absence of localized exophytic
lesions. Giant BCC is an uncommon skin tumor variant
defined as a lesion greater than 5 cm at its largest diameter.
It displays a more aggressive biological behavior, resulting
in a higher risk of local invasion and metastasis. Giant BCC
is frequently associated with patient neglect, aggressive his-
tological features, previous radiotherapy and long duration.
In contrast to ordinary BCC, which is preferentially located
in photo-exposed areas, the most frequent localization of
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Figure 1. A) Clinical appearance showing a large and cir-
cumferential ulcer located on the right leg. Histopathological
ulcer mapping with several biopsies (arrows) taken from its
borders (6 specimens) and wound bed (2 specimens) B) Histo-
pathological features of giant basal cell carcinoma. Low
power magnification showing basal cell carcinoma with
strands and nests of basaloid cells infiltrating the dermis
(hematoxylin-eosin stain; original magnification ×40). Higher
magnification showing a close-up view (hematoxylin-eosin
stain; original magnification ×200). C) Clinical improvement
10 months after completion of local radiation therapy.
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giant BCC is the trunk [3, 4]. Its occurrence in the lower
limbs has been rarely reported in the literature [5].
When a slowly enlarging ulcer is the most prominent clin-
ical feature of BCC (rodent ulcer), it can mimic chronic
venous leg ulcers, leading to misdiagnosis and conse-
quently to a delay in the beginning of appropriate treat-
ment. Surgery is still the preferred therapy for giant BCC,
however, radiotherapy is an alternative with satisfactory
outcomes, particularly in older patients with inoperable
tumours [6].
We report a giant basal cell carcinoma presenting as a
longstanding chronic leg ulcer, emphasising the impor-
tance of taking biopsy specimens of all suspicious and
non-healing leg ulcers. In our experience, local radiation
therapy appears to be an effective non-invasive primary
treatment for giant and unresectable basal cell carcinomas
of the lower limbs. ■
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Mushroom-like soft fibromas on chronic
leg lymphedema
We present an unusual case of soft fibromas on the legs
with lymphedema, seen in a diabetic woman. Only two pre-
ceding cases have been reported [1-3]. Comparison of the
cases disclosed many common features of this condition.
A 47-year-old woman noticed a hot sensation bilaterally
on her legs in July 2004. She had leg edema of two years’
duration and a yellowish normal skin colored tumor for
1 year. She had had systemic lupus erythematosus for
22 years and corticosteroid-induced diabetes mellitus for
10 years. She had also lupus nephritis and was treated
with prednisolone (20-30 mg) and cyclophosphamide for
9 years. No surgical procedure, which could be related to
leg edema, was documented. Physical examination
revealed that her weight was 125 kg; height was
160 cm; and her temperature was 38.9 °C. Her legs
were markedly swollen with diffuse erythema. There
were up to 2-3 cm sized, partially violaceous, yellow-
skin colored elastic soft nodules and tumors on both legs
with no exudation. Inguinal lymph nodes were not palpa-
ble. Complete blood count showed white blood cells,
11,400/mm3 (normal; 3000-7800/mm3); hemoglobin,
10.4 g/dL (normal; 10.4-14.4 g/dL); total protein,
4.8 g/dL (normal; 6.5-8.0 g/dL); and albumin, 3.0 g/dL
(normal; 4.0-5.2 g/dL). Liver function tests were mostly
normal. BUN and creatinine were raised to 51.2 mg/dL
(7.0-24.0 mg/dL) and 3.65 mg/dL (0.4-0.9 mg/dL), res-
pectively. C-reactive protein showed 29.94 mg/dL
(< 0.5 mg/dL). She was admitted to our hospital under
the diagnosis of cellulitis with lymphedema, and antibio-
tics with γ-globulin therapy were initiated to control
severe infection, with a good response.
She had similar episodes of cellulitis in April, May and
July 2005 (figure 1A). During the course, yellowish nor-
mal skin-colored mushroom-like tumors increased in
number and enlarged on her legs. The tumors were more





Figure 1. Clinical presentation of the skin tumors. The
lesions were up to 2-3 cm sized, partially violaceous,
yellow-skin colored, elastic soft tumors and nodules. These
tumors are enlarged and increased in number, and presented
as mushroom-like (Jul. 2005). B) Almost all fibromas are
subsiding. Most but not all the tumors are gone. (Sep.
2007). C) Histopathological findings (Hematoxylin-Eosin
stain). Low magnification (×40). Dome-shaped pedunculated
tumor. Inflammatory infiltrate is observed. Hyper-vascularity
and dilated vessels are noted.
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